Posted inPharmaceutical
Novartis Q3 2026 Results: What the Del-Desiran Write-Down Says About Pipeline Risk
What the Novartis Q3 2026 results reveal about its drug pipeline, the Avidity deal and rare-disease risk after the HARBOR trial miss.
Posted inPharmaceutical
AstraZeneca Stomach Cancer Drug Trial: Why Progression-Free Survival Missed
The AstraZeneca stomach cancer drug trial won on survival but missed progression-free survival at p=0.053. How to read both results.
Posted inPharmaceutical
Takeda Gastric Cancer Drug Trial: Who Benefits From the Claudin 18.2 ADC
Who does the Takeda gastric cancer drug trial apply to? Claudin 18.2-positive, heavily pretreated patients in Japan and China. Data and limits.
Posted inPharmaceutical
Roche Divarasib Phase 3 Trial: How to Read the KRASCENDO 1 Results
The Roche divarasib Phase 3 trial explained: who was enrolled, which drugs it beat, what is interim and what remains unknown.
Posted inPharmaceutical
Roche Q3 2026 Results Put Patent Expiries and Biosimilar Pressure in Focus
The Roche Q3 2026 results beat forecasts, but the Xolair shortfall and looming patent expiries show the pressure on older blockbusters.
Posted inPharmaceutical
Natco Generic Risdiplam: What a ₹15,900 SMA Drug Means for Rare Disease Pricing
The Natco generic risdiplam costs ₹15,900 a bottle against ₹6.2 lakh for Evrysdi. What approval, bioequivalence and families’ concerns involve.
Posted inPharmaceutical
Malaria Vaccine Price Cut by 40% as Bharat Biotech Prepares to Take Over Mosquirix Production
The Mosquirix malaria vaccine price cut brings the price to €5.50 a dose as Bharat Biotech takes over production from GSK. Conditions apply.
Posted inPharmaceutical
How the Personalised mRNA Melanoma Vaccine From Moderna and Merck Works
How the Moderna Merck melanoma vaccine is personalised from a patient’s tumour, and what its Phase 3 results with Keytruda showed so far.
Posted inPharmaceutical
Cheap Chinese Antibiotic Imports Test Europe’s Last Integrated Penicillin Plant
Penicillin manufacturing Europe still has rests on Sandoz’s Kundl plant. What the anti-dumping complaint is, and what may follow.
Posted inPharmaceutical
Climara Pro Generic Approved: What Zydus’s Patch Means for Patients
Climara Pro generic explained: Zydus won USFDA approval for an estradiol and levonorgestrel patch. What a generic is and what to ask your doctor.